RecruitingNot ApplicableNCT05703620

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions - the RESURRECT Trial. A Pilot Proof-of-concept and Safety Study With the Paradise Denervation System


Sponsor

Royal Perth Hospital

Enrollment

75 participants

Start Date

Oct 8, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The is a non-randomized pilot trial, open-label evaluation of the physiologic response of native kidney denervation using the Paradise denervation system in CKD, End Stage Renal Disease (ESRD), and Heart failure (HF)


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a procedure called ultrasound-guided renal denervation — where sound waves are used to disrupt overactive nerve signals from the kidneys — in people with serious cardiovascular and kidney conditions. The goal is to reduce the excessive nervous system activity that strains the heart and blood vessels. **You may be eligible if...** - You are between 18 and 75 years old - You have moderate to advanced chronic kidney disease (stage 3a or 3b), are on dialysis, or have mild to moderate heart failure with reduced pumping function - You are willing and able to provide informed consent **You may NOT be eligible if...** - You have anatomy that makes the procedure technically not possible - You have had a heart attack, stroke, or unstable chest pain in the past 3 months - You have been hospitalized for worsening heart failure in the past month - You have a serious inflammatory bowel condition (Crohn's or ulcerative colitis) - You are pregnant - You have a history of drug or alcohol dependency - You are currently in another clinical trial of an investigational device or drug Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERenal Denervation

All eligible participants receive ultrasound based renal denervation to both kidneys on all eligible vessels


Locations(1)

Royal Perth Hospital

Perth, Western Australia, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05703620


Related Trials